Video caption: These mice are siblings and genetically identical. In the one on the right, we turned DUX4 “on”, while in the one on the left, the DUX4 gene remained… Read More »
Promising FSHD mouse model from Harper lab
A tunable FSHD-like DUX4 mouse model
by Peter Jones, PhD, and Takako Jones, PhD, University of Nevada, Reno The aberrant expression of the DUX4 primate retrotransposon is the key mediator of all forms of FSHD. Thus,… Read More »
On patient registries: findings from our suvey
Last November, the FSH Society invited its members to participate in a survey designed to gauge what members understand about patient registries and for researchers to gain insight into what kind of… Read More »
Acceleron adds 2 new sites for ACE-083 clinical trial
Cambridge, Massachusetts-based Acceleron Pharma, Inc., is now recruiting adults with FSH muscular dystrophy for a Phase 2 clinical trial of ACE-083 at sites in Kansas City, KS, and Rochester, NY,… Read More »
Global FSHD Registry Workshop
International workshop in November reaches consensus on a global FSHD patient registry. If you are an individual with FSHD, or a family member, you may have been asked to join a… Read More »